Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Novan
About
Novan is a clinical-stage drug development company developing deliverable nitric oxide.
- 101 - 250
Details
- Last Funding Type
- Private Equity（PE）
- Last Funding Money Raised
- $50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2008
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Novan develops products that tap the anti-bacterial properties of nitric oxide by encapsulating the compound in nano-particles that deliver therapeutic agents to desired body location. They use its proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs.The company is committed to using the power of the human body to create safe and effective treatments. They complement their internal scientific talent with strategic partners around the globe to enable Novan to harness the power of nitric oxide and develop technologies that will help address currently untreated and under-treated medical conditions.It was incorporated in 2008 and is based in Morrisville, North Carolina.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 30, 2015 | Private Equity（PE） | $50M | 1 |
Malin Corporation
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Dec 28, 2021
Ready Player Me
|
Series A | $13M | 3D Technology | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Malin Corporation
|
Yes | Private Equity（PE） |
